TRIALs: Open Studies | "Niacin" - List Results - ClinicalTrials.gov

Found 38 studies with search of: Open Studies | "Niacin"
Include studies that are not seeking new volunteers.


► 1 Recruiting The Role of Dyslipidemia and Extended-Release Niacin in Stroke Recovery
Condition: Ischemic Stroke
Interventions: Drug: Extended-Release Niacin; Drug: Placebo
[full-text:
The Role of Dyslipidemia and Extended-Release Niacin in Stroke Recovery - Full Text View - ClinicalTrials.gov]


► 2 Not yet recruiting Flexible Doses of Niacin (Niaspan) as an Adjunct to Antipsychotic Medication in the Treatment of First Episode Psychosis
Condition: Cognition
Intervention: Drug: Niaspan
[full-text:
Flexible Doses of Niacin (Niaspan) as an Adjunct to Antipsychotic Medication in the Treatment of First Episode Psychosis - Full Text View - ClinicalTrials.gov]


► 3 Recruiting Niacin and Endothelial Function in Early CKD
Condition: Chronic Kidney Disease
Interventions: Drug: Niacin; Drug: Active Placebo
[full-text: Niacin and Endothelial Function in Early CKD - Full Text View - ClinicalTrials.gov]


► 4 Not yet recruiting Niacin/Laropiprant and Endothelial Function
Condition: Coronary Heart Disease
Interventions: Drug: Niacin/laropiprant; Drug: Placebo
[full-text: Niacin/Laropiprant and Endothelial Function - Full Text View - ClinicalTrials.gov]


► 5 Recruiting A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction
Conditions: Hyperlipidemia; Hypercholesterolemia
Interventions: Drug: ezetimibe; Drug: niacin; Drug: colestipol
[full-text: A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction - Full Text View - ClinicalTrials.gov]


► 6 Not yet recruiting Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (Protocol MK-0524A-133)
Condition: Primary Hypercholesterolemia; Mixed Dyslipidemia
Interventions: Drug: Extended-release niacin/laropiprant (ERN/LRPT); Drug: Placebo
[full-text: Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (Protocol MK-0524A-133) - Full Text View - ClinicalTrials.gov]


► 7 Recruiting Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis
Conditions: Aortocoronary Saphenous Vein Bypass Graft Atherosclerosis; Intermediate Saphenous Vein Graft Lesions
Intervention: Drug: extended-release niacin (Niaspan)
[full-text: Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis - Full Text View - ClinicalTrials.gov]


► 8 Recruiting Colesevalam Treatment for Impaired Fasting Glucose During Niacin Therapy
Conditions: Dyslipidemia; Hyperlipidemia; Hyperglycemia
Interventions: Drug: placebo; Drug: colesevelam
[full-text: Colesevalam Treatment for Impaired Fasting Glucose During Niacin Therapy - Full Text View - ClinicalTrials.gov]


► 9 Recruiting Niacin to Improve Blood Flow in People With Sickle Cell Disease
Condition: Sickle Cell Disease
Interventions: Drug: Niacin-ER; Drug: Placebo; Drug: L-NMMA; Drug: Acetylcholine
[full-text: Niacin to Improve Blood Flow in People With Sickle Cell Disease - Full Text View - ClinicalTrials.gov]


► 10 Recruiting Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)
Condition: Coronary Artery Disease
Interventions: Drug: Niacin; Drug: Niacin+Statin
[full-text: Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD) - Full Text View - ClinicalTrials.gov]


► 11 Recruiting The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study
Condition: Healthy Volunteers
Intervention: Drug: Immediate Release Niacin, Extended Release Niacin, Endotoxin
[full-text: The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study - Full Text View - ClinicalTrials.gov]


► 12 Not yet recruiting Effect of Nicotinic Acid on Cardiovascular Risks Indices in Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome
Interventions: Drug: tredaptive (nicotinic acid/ laropiprant); Drug: placebo
[full-text: Effect of Nicotinic Acid on Cardiovascular Risks Indices in Polycystic Ovary Syndrome - Full Text View - ClinicalTrials.gov]


► 13 Not yet recruiting Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia
Conditions: Hyperlipoproteinemia; Metabolic Syndrome
Intervention: Drug: Niacin/ Laropiprant
[full-text: Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia - Full Text View - ClinicalTrials.gov]


► 14 Recruiting To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions
Condition: Retinal Vein Occlusion
Interventions: Drug: Nicotinic acid; Drug: Prednisolone acetate
[full-text: To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions - Full Text View - ClinicalTrials.gov]


► 15 Recruiting Pioglitazone Vs Placebo in Combination With Niacin Extended Release on Low HDL
Condition: Metabolic Syndrome
Intervention: Drug: Pioglitazone +/- placebo in combination with niacin ER
[full-text: Pioglitazone Vs Placebo in Combination With Niacin Extended Release on Low HDL - Full Text View - ClinicalTrials.gov]


► 16 Recruiting Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis
Condition: Healthy Volunteers
Interventions: Drug: Niacin; Other: Placebo
[full-text: Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis - Full Text View - ClinicalTrials.gov]


► 17 Recruiting Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia
Condition: Dyslipidemia
Interventions: Drug: High-dose rosuvastatin; Drug: Statin plus fenofibrate; Drug: Statin plus niacin ER/laropiprant
[full-text: Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia - Full Text View - ClinicalTrials.gov]


► 18 Recruiting Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients
Conditions: Chronic Renal Failure; Hemodialysis
Interventions: Drug: nicotinamide; Drug: sevelamer; Drug: cinacalcet
[full-text: Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients - Full Text View - ClinicalTrials.gov]


► 19 Recruiting Effect of Nicotinic Acid on Adipose Tissue Inflammation in Obese Subjects
Condition: Obesity
Interventions: Behavioral: training; Drug: nicotinic acid; Drug: Placebo
[full-text: Effect of Nicotinic Acid on Adipose Tissue Inflammation in Obese Subjects - Full Text View - ClinicalTrials.gov]

► 20 Not yet recruiting Nicotinic Acid - Pharmacokinetics, Pharmacodynamics, Receptor Expression
Condition: Healthy
Intervention: Drug: nicotinic acid
[full-text: Nicotinic Acid - Pharmacokinetics, Pharmacodynamics, Receptor Expression - Full Text View - ClinicalTrials.gov]


full-text:
Search of: Open Studies | "Niacin" - List Results - ClinicalTrials.gov